izpis_h1_title_alt

Identification and validation of new cancer stem cell-related genes and their regulatory microRNAs in colorectal cancerogenesis
ID Urh, Kristian (Author), ID Žlajpah, Margareta (Author), ID Zidar, Nina (Author), ID Boštjančič, Emanuela (Author)

.pdfPDF - Presentation file, Download (4,05 MB)
MD5: 2877AF26AD413F5C8A8E0E40202ABFFE
URLURL - Source URL, Visit https://www.mdpi.com/2227-9059/9/2/179 This link opens in a new window

Abstract
Significant progress has been made in the last decade in our understanding of the pathogenetic mechanisms of colorectal cancer (CRC). Cancer stem cells (CSC) have gained much attention and are now believed to play a crucial role in the pathogenesis of various cancers, including CRC. In the current study, we validated gene expression of four genes related to CSC, L1TD1, SLITRK6, ST6GALNAC1 and TCEA3, identified in a previous bioinformatics analysis. Using bioinformatics, potential miRNA-target gene correlations were prioritized. In total, 70 formalin-fixed paraffin-embedded biopsy samples from 47 patients with adenoma, adenoma with early carcinoma and CRC without and with lymph node metastases were included. The expression of selected genes and microRNAs (miRNAs) was evaluated using quantitative PCR. Differential expression of all investigated genes and four of six prioritized miRNAs (hsa-miR-199a-3p, hsa-miR-335-5p, hsa-miR-425-5p, hsa-miR-1225-3p, hsa-miR-1233-3p and hsa-miR-1303) was found in at least one group of CRC cancerogenesis. L1TD1, SLITRK6, miR-1233-3p and miR-1225-3p were correlated to the level of malignancy. A negative correlation between miR-199a-3p and its predicted target SLITRK6 was observed, showing potential for further experimental validation in CRC. Our results provide further evidence that CSC-related genes and their regulatory miRNAs are involved in CRC development and progression and suggest that some them, particularly miR-199a-3p and its SLITRK6 target gene, are promising for further validation in CRC.

Language:English
Keywords:colorectal cancer, differentially expressed genes, cancer stem cells, qPCR
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2021
Number of pages:20 str.
Numbering:Vol. 9, iss. 2, art. 179
PID:20.500.12556/RUL-135037 This link opens in a new window
UDC:616-006
ISSN on article:2227-9059
DOI:10.3390/biomedicines9020179 This link opens in a new window
COBISS.SI-ID:53489155 This link opens in a new window
Publication date in RUL:18.02.2022
Views:540
Downloads:119
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biomedicines
Shortened title:Biomedicines
Publisher:MDPI AG
ISSN:2227-9059
COBISS.SI-ID:523006745 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:11.02.2021

Secondary language

Language:Slovenian
Keywords:kolorektalni rak, različno izraženi geni, matične celice raka

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0054
Name:Patologija in molekularna genetika

Funder:ARRS - Slovenian Research Agency
Project number:J3-1754
Name:Novi prognostični in diagnostični označevalci v razvoju raka debelega črevesa in danke

Funder:ARRS - Slovenian Research Agency
Funding programme:PhD research funding

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back